Pennington Biomedical Research Center, Louisiana State University, 6400 Perkins Rd, Baton Rouge, LA, 70808, USA,
J Cachexia Sarcopenia Muscle. 2014 Mar;5(1):9-18. doi: 10.1007/s13539-014-0130-5. Epub 2014 Feb 15.
Even though skeletal muscle (SM) is the largest body compartment in most adults and a key phenotypic marker of sarcopenia and cachexia, SM mass was until recently difficult and often impractical to quantify in vivo. This review traces the historical development of SM mass measurement methods and their evolution to advances that now promise to provide in-depth noninvasive measures of SM composition.
Key steps in the advancement of SM measurement methods and their application were obtained from historical records and widely cited publications over the past two centuries. Recent advances were established by collecting information on notable studies presented at scientific meetings and their related publications.
The year 1835 marks the discovery of creatine in meat by Chevreul, a finding that still resonates today in the D3-creatine method of measuring SM mass. Matiegka introduced an anthropometric approach for estimating SM mass in 1921 with the vision of creating a human "capacity" marker. The 1940s saw technological advances eventually leading up to the development of ultrasound and bioimpedance analysis methods of quantifying SM mass in vivo. Continuing to seek an elusive SM mass "reference" method, Burkinshaw and Cohn introduced the whole-body counting-neutron activation analysis method and provided some of the first detailed reports of cancer cachexia in the late 1970s. Three transformative breakthroughs leading to the current SM mass reference methods appeared in the 1970s and early 1980s as follows: the introduction of computed tomography (CT), photon absorptiometry, and magnetic resonance (MR) imaging. Each is advanced as an accurate and/or practical approach to quantifying whole-body and regional SM mass across the lifespan. These advances have led to a new understanding of fundamental body size-SM mass relationships that are now widely applied in the evaluation and monitoring of patients with sarcopenia and cachexia. An intermediate link between SM mass and function is SM composition. Advances in water-fat MR imaging, diffusion tensor imaging, MR elastography, imaging of connective tissue structures by ultra-short echo time MR, and other new MR approaches promise to close the gap that now exists between SM anatomy and function.
The global efforts of scientists over the past two centuries provides us with highly accurate means by which to measure SM mass across the lifespan with new advances promising to extend these efforts to noninvasive methods for quantifying SM composition.
尽管骨骼肌(SM)是大多数成年人身体最大的部位,也是肌肉减少症和恶病质的关键表型标志物,但直到最近,SM 质量仍难以在体内进行定量,且通常不切实际。本综述追溯了 SM 质量测量方法的历史发展及其演进步伐,这些进展有望为深入了解 SM 成分提供非侵入性的测量方法。
从过去两个世纪的历史记录和广泛引用的出版物中获取了 SM 测量方法的关键步骤及其应用的发展情况。通过收集科学会议上发表的重要研究及其相关出版物的信息,确定了最近的进展。
1835 年,Chevreul 在肉类中发现了肌酸,这一发现至今仍在 D3-肌酸测量 SM 质量的方法中产生共鸣。Matiegka 于 1921 年提出了一种人体测量方法来估计 SM 质量,他的愿景是创建一个人体“容量”标志物。20 世纪 40 年代,技术进步最终导致了超声和生物阻抗分析方法的发展,这些方法可在体内定量测量 SM 质量。为了继续寻找难以捉摸的 SM 质量“参考”方法,Burkinshaw 和 Cohn 在 20 世纪 70 年代末引入了全身计数-中子激活分析方法,并提供了一些关于癌症恶病质的首批详细报告。三项变革性突破在 20 世纪 70 年代和 80 年代初出现,分别为:计算机断层扫描(CT)、光子吸收测量法和磁共振(MR)成像的引入。每一种方法都被认为是定量评估和监测肌肉减少症和恶病质患者的全身体积和区域 SM 质量的准确且实用的方法。这些进展使我们对基本的身体大小-SM 质量关系有了新的认识,这些关系现在已广泛应用于对肌肉减少症和恶病质患者的评估和监测中。SM 质量和功能之间的中间环节是 SM 成分。水-脂肪磁共振成像、扩散张量成像、MR 弹性成像、超短回波时间磁共振成像的结缔组织结构成像以及其他新的磁共振方法的进展有望缩小目前 SM 解剖学与功能之间的差距。
过去两个世纪以来,全球科学家的努力为我们提供了高度准确的方法来测量整个生命周期中的 SM 质量,新的进展有望将这些努力扩展到用于定量测量 SM 成分的非侵入性方法。